Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 47,667 $ 18,997
Accounts receivable, net of allowance for doubtful accounts of $260 and $39, respectively 43,491 74,307
Inventories 41,767 60,600
Prepaid inventory 891 1,528
Derivative assets 17,149 2,438
Assets held-for-sale 58,295 69,764
Other current assets 4,786 4,430
Total current assets 214,046 232,064
Property and equipment, net 229,486 332,526
Other Assets:    
Right of use operating lease assets, net 11,046 24,346
Notes receivable 14,337
Assets held-for-sale 16,500
Intangible asset 2,678 2,678
Other assets 5,225 4,381
Total other assets 33,286 47,905
Total Assets 476,818 612,495
Current Liabilities:    
Accounts payable – trade 13,047 29,277
Accrued liabilities 11,101 22,331
Current portion – operating leases 2,180 3,457
Current portion – long-term debt, net 25,533 63,000
Derivative liabilities 1,860
Liabilities held-for-sale 19,542 34,413
Other current liabilities 15,524 6,060
Total current liabilities 86,927 160,398
Long-term debt, net of current portion 71,807 180,795
Operating leases, net of current portion 8,715 21,171
Other liabilities 13,134 23,086
Total Liabilities 180,583 385,450
Commitments and contingencies (Notes 1, 8, 9, 10 and 15)
Stockholders’ Equity:    
Preferred stock, value
Common stock, value 72 56
Additional paid-in capital 1,036,638 942,307
Accumulated other comprehensive loss (3,878) (2,370)
Accumulated deficit (736,598) (720,214)
Total Alto Ingredients, Inc. stockholders’ equity 296,235 219,780
Noncontrolling interests 7,265
Total stockholders’ equity 296,235 227,045
Total Liabilities and Stockholders’ Equity 476,818 612,495
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value 1 1
Non-Voting Common Stock    
Stockholders’ Equity:    
Common stock, value